Expert Panel Approves Post-Marketing Surveillance Study of Eculizumab (Soliris) by AstraZeneca in India Dr. Divya Colin6 July 2025 3:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to...
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III Trial Dr. Divya Colin1 Jun 2025 4:00 PM ISTNew Delhi: Reviewing the Phase III clinical of the Ianalumab (VAY736) presented by Novartis, the Subject Expert Committee (SEC) functional under the...
Pfizer Gets CDSCO Panel Nod To study Marstacimab Dr. Divya Colin4 April 2025 6:00 PM ISTNew Delhi: The pharmaceutical major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
submit phase I and phase II data for Crohn's disease: CDSCO Panel tells Roche Products India on RO7790121 study Dr. Divya Colin22 March 2025 6:00 PM ISTNew Delhi: Reviewing Phase III clinical study protocol of the monoclonal antibody RO7790121, the Subject Expert Committee (SEC) functional under the...
Prenatal Vaccination and Infant Monoclonal Antibody Combo Effective RSV Prevention Strategy: JAMA Medha Baranwal24 Feb 2025 8:45 PM ISTUSA: Researchers have found in a new study that a respiratory syncytial virus (RSV) prevention strategy combining prenatal vaccination and infant...
Biocon Biologics secures market entry for Bmab 1200 in Europe, UK, Canada, Japan Ruchika Sharma29 Aug 2024 12:30 PM ISTBangalore: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, announced today that the...
Efficacy and Safety of Bimekizumab in Treating Hidradenitis Suppurativa Demonstrated in Phase 3 Trials Medha Baranwal30 Jun 2024 8:00 PM ISTUSA: Bimekizumab, a novel monoclonal antibody, has shown promising results in treating moderate-to-severe hidradenitis suppurativa (HS), a chronic...
Pamrevlumab Shows No Significant Benefit in Slowing Lung Function Decline in Idiopathic Pulmonary Fibrosis: JAMA Dr Riya Dave27 May 2024 8:00 AM ISTResearchers have found that pamrevlumab, a monoclonal antibody, does not significantly slow the decline in lung function for patients with idiopathic...
Monoclonal Antibody Shows Promise in Preventing Malaria in Children, reports study Dr Riya Dave8 May 2024 9:00 AM ISTResearchers have found that a single subcutaneous injection of an investigational monoclonal antibody called L9LS significantly reduces the risk of...
Ofatumumab subcutaneous injection promising treatment option for refractory pemphigus vulgaris: Study Medha Baranwal4 March 2024 2:00 AM ISTChina: A recent study published in The Journal of Dermatology has suggested ofatumumab to be a promising treatment option for patients with refractory...
Sun Pharma Gets CDSCO Panel Nod to Study Tildrakizumab Injection 100 mg/ ml Dr. Divya Colin16 Feb 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Nipah Alert: One more tests positive, Centre to get 20 more doses of antibody from Australia Adity Saha16 Sept 2023 5:56 PM ISTKozhikode: India's southern state of Kerala shut some schools and offices this week as officials raced to halt the spread of the deadly Nipah virus...
